Strategic exit Greyrock recently exited assets via sale to Avista Healthcare Partners in 2026, indicating a potential pool of buyers and a readiness to divest non-core assets. This suggests opportunities to discuss mezzanine debt or equity solutions for similar portfolio optimization or liquidity events.

Portfolio activity Historical acquisitions in manufacturing and medical devices show Greyrock’s experience with middle-market companies in regulated sectors. Leverage this to position targeted financing, growth capital, or recapitalization services for portfolio companies in healthcare devices or electronics.

Industry focus Active involvement in real estate and investments in diversified industries imply a broad appetite for capital solutions across asset-heavy and capital-intensive businesses. Potential to offer asset-backed lending, structured finance, or growth equity to operating companies with real assets.

Partnership history Past collaborations with private equity partners like Hermitage Equity and Clavis Capital Partners indicate a network-friendly approach. This opens doors to co-investment opportunities, referral channels, and partnerships for large-scale financing rounds.

Scale and reach Small internal team (2-10 employees) combined with a track record of deals across geographies suggests a preference for streamlined, partner-driven engagement. Emphasize flexible, fast-close SPV structures, lightweight due diligence, and turnkey financing solutions to accelerate opportunities.